【レポートの概要（一部）】
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. MARKET DEFINITION AND SCOPE
2.2. KEY FINDINGS
2.3. PARAMETRIC ANALYSIS
2.3.1. PREVALENCE & INCIDENCE RATE OF ALZHEIMER’S DISEASE
2.3.2. HOSPITAL AND RESEARCH CENTER ACROSS GEOGRAPHIES
2.3.3. PREVALENCE & INCIDENCE RATE OF PARKINSON’S DISEASE
2.3.4. PREVALENCE & INCIDENCE RATE OF CANCER DISEASE
2.3.5. HEALTHCARE EXPENDITURE ACROSS GEOGRAPHIES
2.4. KEY MARKET INSIGHTS
2.4.1. TOP 3 EMERGING COUNTRIES
2.4.2. TOP 3 REVENUE GENERATING SEGMENTS
2.4.3. TOP GROWING MARKETS AND EMERGING TRENDS
2.4.4. TOP 3 GEOGRAPHY
2.5. COMPETITIVE LANDSCAPE
2.5.1. MARKET SHARE ANALYSIS
2.5.2. TOP WINNING STRATEGIES
2.5.3. CASE STUDIES: TOP COMPETITIVE MOVES
2.6. PORTER’S FIVE FORCE MODEL
2.6.1. THREAT OF NEW ENTRANTS
2.6.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
2.6.3. BARGAINING POWER OF BUYER
2.6.4. BARGAINING POWER OF SUPPLIER
2.6.5. INTENSITY OF COMPETITIVE RIVALRY
2.7. KEY BUYING CRITERIA
2.8. STRATEGIC RECOMMENDATION
2.9. STRATEGIC CONCLUSIONS
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. DEVELOPMENT IN PROTEOMICS, GENOMICS AND IMAGING SYSTEM HAS INCREASED DEMAND FOR CNS BIOMARKER.
3.1.2. FUNDING FROM GOVERNMENT AND PRIVATE PLAYERS TO BOOST CNS BIOMARKER MARKET
3.1.3. GROWTH IN LIFE STYLE ORIENTED DISEASES
3.1.4. GROWTH IN GOVERNMENT AND PRIVATE FUNDING IN CNS BIOMARKER MARKET
3.1.5. GROWTH IN PUBLIC-PRIVATE PARTNERSHIP
3.1.6. FDA APPROVALS GIVING RISE TO SIGNIFICANT SCOPE IN BIOMARKER MARKET
3.1.7. TECHNOLOGICAL ADVANCEMENT ENABLES TO EXPAND CNS BIOMARKER MARKET
3.1.8. INNOVATION GIVING RISE TO GROWTH OF CNS BIOMARKER MARKET
3.1.9. GLOBAL INCREASE IN HEALTHCARE EXPENDITURE
3.2. MARKET RESTRAINTS
3.2.1. HIGH COST OF CNS BIOMARKER TEST AND DIAGNOSTICS
3.2.2. REIMBURSEMENT ISSUES AFFECTING THE CNS BIOMARKER MARKET
3.3. MARKET OPPORTUNITIES
3.3.1. INCREASING ADOPTION OF PERSONALIZED MEDICINES
3.3.2. UNTAPPED APAC REGION HAS HUGE SCOPE FOR CNS BIOMARKER MARKET
3.3.3. GLOBAL INCREASE IN AGING POPULATION HAS CREATED HUGE SCOPE FOR CNS BIOMARKER MARKET
3.3.4. FAVORABLE GOVERNMENT POLICIES AND SUPPORT FOR CNS BIOMARKERS
3.4. MARKET CHALLENGES
3.4.1. CREATING AWARENESS FOR CNS BIOMARKER MARKET
3.4.2. GLOBAL ECONOMIC SLOWDOWN MAY AFFECT THE CNS BIOMARKER MARKET
3.4.3. TECHNICAL ISSUES OF SAMPLE COLLECTION AND STORAGE
3.5. PARENT MARKET
3.6. COMPETITORS MARKET
3.7. ALTERNATIVE MARKET
4. MARKET SEGMENTATION
4.1. GLOBAL CNS BIOMARKER MARKET BY APPLICATION, 2014-2022,($ MILLIONS)
4.1.1. GLOBAL DIAGNOSTIC DEVELOPMENT MARKET, 2014-2022,($ MILLIONS)
4.1.2. GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET, 2014-2022,($ MILLIONS)
4.1.3. GLOBAL PERSONALIZED MEDICINE MARKET, 2014-2022,($ MILLIONS)
4.1.4. GLOBAL DISEASE RISK ASSESSMENT MARKET, 2014-2022,($ MILLIONS)
4.1.5. GLOBAL OTHER MARKET , 2014-2022,($ MILLIONS)
4.2. GLOBAL CNS BIOMARKER MARKET BY TYPE, 2014-2022,($ MILLIONS)
4.2.1. GLOBAL SAFETY BIOMARKER MARKET , 2014-2022,($ MILLIONS)
4.2.2. GLOBAL EFFICACY BIOMARKER MARKET, 2014-2022,($ MILLIONS
4.2.3. GLOBAL PREDICTIVE BIOMARKER MARKET, 2014-2022,($ MILLIONS)
4.2.4. GLOBAL PHARMACODYNAMIC BIOMARKER MARKET, 2014-2022,($ MILLIONS)
4.2.5. GLOBAL PROGNOSTIC BIOMARKER MARKET, 2014-2022,($ MILLIONS)
4.2.6. GLOBAL VALIDATION BIOMARKER MARKET, 2014-2022,($ MILLIONS)
4.3. GLOBAL CNS BIOMARKER MARKET BY END USERS, 2014-2022,($ MILLIONS)
4.3.1. GLOBAL CNS BIOMARKER MARKET BY HOSPITALS, 2014-2022,($MILLIONS)
4.3.2. GLOBAL CNS BIOMARKER MARKET BY EYE CLINICS, 2014-2022,($MILLIONS)
4.3.3. GLOBAL CNS BIOMARKER MARKET BY DIAGNOSTIC CENTERS, 2014-2022,($MILLIONS)
4.3.4. GLOBAL CNS BIOMARKER MARKET BY PATIENTS, 2014-2022,($MILLIONS)
5. GEOGRAPHICAL ANALYSIS
5.1. NORTH AMERICA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.1.1. UNITED STATES (U.S.) CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.1.2. CANADA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.2. EUROPE CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.2.1. UNITED KINGDOM (UK) CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.2.2. FRANCE CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.2.3. GERMANY CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.2.4. SPAIN CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.2.5. ITALY CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.2.6. ROE CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.3. ASIA PACIFIC CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.3.1. INDIA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.3.2. CHINA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.3.3. JAPAN CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.3.4. ROAPAC CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.4. REST OF THE WORLD CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.4.1. LATIN AMERICA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.4.2. MENA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
5.4.3. AFRICA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
6. COMPANY PROFILING: – (OVER, SCOT ANALYSIS, STRATEGIC REVIEW)
1. ABASTAR MDX INC
2. ABIANT INC
3. ACUMEN PHARMACEUTICALS INC
4. ADLYFE INC
5. ALSERES PHARMACEUTICALS INC
6. APITOPE INTERNATIONAL
7. APOSENSE
8. APPLIED NEUROSOLUTIONS INC
9. AVACTA GROUP PLC
10. AVID RADIOPHARMACEUTICALS INC
11. BANYAN BIOMARKERS
12. DIAGENIC ASA
13. EKFDIAGNOSTICS HOLDINGS INC
14. ENZO BIOCHEM INC
15. EXONHIT THERAPEUTICS
16. GENENEWS LTD
17. GLYCOMINDS LTD
18. GREAT LAKES NEUROTECHNOLOGIES
19. INNOGENETICS BIOLOGICALS
20. INNOVATIVE NEUROTECHNOLOGIES INC
21. MERC & CO. IN
22. METABOLON INC
23. MYRIAD RBM INC
24. OLIGOMERIX INC
25. OPKO HEALTH INC
26. OSTA BIOTECHNOLOGIES INC
27. PROTEOME SCIENCES PRODUCTS
28. PSYNOVA NEUROTECH LTD
29. RIDGE DIAGNOSTICS
30. SABIOSCIENCES
31. SATORI PHARMACEUTICAL INC
32. THERMO FISHER SCIENTIFIC
LIST OF TABLES
1. GLOBAL DIAGNOSTIC DEVELOPMENT MARKET, 2014-2022,($ MILLIONS)
2. GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET, 2014-2022,($ MILLIONS)
3. GLOBAL PERSONALIZED MEDICINE MARKET, 2014-2022,($ MILLIONS)
4. GLOBAL DISEASE RISK ASSESSMENT MARKET, 2014-2022,($ MILLIONS)
5. GLOBAL OTHER MARKET , 2014-2022,($ MILLIONS)
6. GLOBAL SAFETY BIOMARKER MARKET , 2014-2022,($ MILLIONS)
7. GLOBAL EFFICACY BIOMARKER MARKET, 2014-2022,($ MILLIONS
8. GLOBAL PREDICTIVE BIOMARKER MARKET, 2014-2022,($ MILLIONS)
9. GLOBAL PHARMACODYNAMIC BIOMARKER MARKET, 2014-2022,($ MILLIONS)
10. GLOBAL PROGNOSTIC BIOMARKER MARKET, 2014-2022,($ MILLIONS)
11. GLOBAL VALIDATION BIOMARKER MARKET, 2014-2022,($ MILLIONS)
12. GLOBAL CNS BIOMARKER MARKET BY HOSPITALS, 2014-2022,($MILLIONS)
13. GLOBAL CNS BIOMARKER MARKET BY EYE CLINICS, 2014-2022,($MILLIONS)
14. GLOBAL CNS BIOMARKER MARKET BY DIAGNOSTIC CENTERS, 2014-2022,($MILLIONS)
15. GLOBAL CNS BIOMARKER MARKET BY PATIENTS, 2014-2022,($MILLIONS)
16. NORTH AMERICA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
17. UNITED STATES (U.S.) CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
18. CANADA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
19. EUROPE CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
20. UNITED KINGDOM (UK) CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
21. FRANCE CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
22. GERMANY CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
23. SPAIN CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
24. ITALY CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
25. ROE CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
26. ASIA PACIFIC CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
27. INDIA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
28. CHINA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
29. JAPAN CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
30. ROAPAC CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
31. REST OF THE WORLD CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
32. LATIN AMERICA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
33. MENA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
34. AFRICA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
LIST OF FIGURES
1. GLOBAL DIAGNOSTIC DEVELOPMENT MARKET, 2014-2022,($ MILLIONS)
2. GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET, 2014-2022,($ MILLIONS)
3. GLOBAL PERSONALIZED MEDICINE MARKET, 2014-2022,($ MILLIONS)
4. GLOBAL DISEASE RISK ASSESSMENT MARKET, 2014-2022,($ MILLIONS)
5. GLOBAL OTHER MARKET , 2014-2022,($ MILLIONS)
6. GLOBAL SAFETY BIOMARKER MARKET , 2014-2022,($ MILLIONS)
7. GLOBAL EFFICACY BIOMARKER MARKET, 2014-2022,($ MILLIONS
8. GLOBAL PREDICTIVE BIOMARKER MARKET, 2014-2022,($ MILLIONS)
9. GLOBAL PHARMACODYNAMIC BIOMARKER MARKET, 2014-2022,($ MILLIONS)
10. GLOBAL PROGNOSTIC BIOMARKER MARKET, 2014-2022,($ MILLIONS)
11. GLOBAL VALIDATION BIOMARKER MARKET, 2014-2022,($ MILLIONS)
12. GLOBAL CNS BIOMARKER MARKET BY HOSPITALS, 2014-2022,($MILLIONS)
13. GLOBAL CNS BIOMARKER MARKET BY EYE CLINICS, 2014-2022,($MILLIONS)
14. GLOBAL CNS BIOMARKER MARKET BY DIAGNOSTIC CENTERS, 2014-2022,($MILLIONS)
15. GLOBAL CNS BIOMARKER MARKET BY PATIENTS, 2014-2022,($MILLIONS)
16. NORTH AMERICA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
17. UNITED STATES (U.S.) CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
18. CANADA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
19. EUROPE CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
20. UNITED KINGDOM (UK) CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
21. FRANCE CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
22. GERMANY CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
23. SPAIN CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
24. ITALY CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
25. ROE CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
26. ASIA PACIFIC CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
27. INDIA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
28. CHINA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
29. JAPAN CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
30. ROAPAC CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
31. REST OF THE WORLD CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
32. LATIN AMERICA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
33. MENA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
34. AFRICA CNS BIOMARKER MARKET, 2014-2022, ($MILLIONS)
【レポート販売概要】
■ タイトル：中枢神経系（CNS）バイオマーカーの世界市場：インサイト、市場機会、市場シェア、市場予測■ 英文：Global Central Nervous System (CNS) Biomarkers Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022
■ 発行日：2016年5月
■ 調査会社：Occams Research
■ 商品コード：OCCAM60703
■ 調査対象地域：グローバル
- 世界の自動車ニードルローラベアリング市場動向：Global Automotive Needle Roller Bearing Market 2014-2018TechNavio's analysts forecast the Global Automotive Needle Roller Bearing market to grow at a CAGR of 3.83 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growing Global Automotive Bearing market. The Global Automotive Needle Roller Bearing market has also been witnessing the increasing demand of bearings from emerging economies. However, the rec …
- Rixubis (Hemophilia A and B)：市場予測と分析（～2022）Rixubis (Hemophilia A and B) - Forecast and Market Analysis to 2022 Summary The competitive landscape of hemophilia A and B recombinant therapy in the US and 5EU is dominated by the use of recombinant FVIII and FIX replacement factors, and patients with severe forms of the disease receive frequent prophylactic infusions beginning from the first one or two years of life and often continuing through …
- がん用の稀用薬パイプライン分析A huge market opportunity is offered by small patient population which suffers from rare or orphan diseases. Among the category of new orphan drugs, Oncology account for the largest disease group in recent years. It has been observed that majority of the orphan drugs in the clinical stages are for rare cancer disease drugs, and are in the late stages of the pipeline. Some of the drugs are being de …
- 冷却塔（フィールド設置型）の世界市場：湿式冷却塔、乾式冷却塔、ハイブリッド式冷却塔The field-erected cooling towers market is expected to reach USD 2.11 Billion by 2021, at a CAGR of 4.3% from 2016 to 2021. The growth of this market is attributed to increasing energy demand and steady economic development along with industrialization in developing countries, such as China, Brazil, and India. Among various end-users for which field-erected cooling towers are employed, the power g …
- 悪性神経膠腫(Malignant Glioma)の治療薬パイプライン動向（2015年上半期版）Malignant Glioma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Malignant Glioma - Pipeline Review, H1 2015’, provides an overview of the Malignant Glioma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Malignant Glioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of …
- 業務用スキンケア製品の世界市場2015-2019About professional skin care The global professional skin care market includes a variety of products that protect the skin against aging, dehydration, pigmentation, sunlight, and cellulite buildup. These products are specially designed for individual skin types. Professional skin care products are generally sold through spas and salons, medical institutions, and retail stores. The global professio …
- 病理学用消耗品の世界市場2018-2022About Pathology Consumables Pathology consumables are laboratory commodities used for the preparation of cell or tissue samples to identify abnormalities in the sample. Technavio’s analysts forecast the Global Pathology Consumables Market to grow at a CAGR of 6.85% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth prospects of the Global Path …
- アクリロニトリル-ブタジエン-スチレン (ABS)の世界市場予測Acrylonitrile-butadiene-styrene copolymer 2013 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about acrylonitrile-butadiene-styrene copolymer market in the all-in-one report issued in a logical and ea …
- 二輪車用スパークプラグの世界市場2017-2021About Two-Wheeler Spark PlugsA spark plug is a device used to transfer electric current to the combustion chamber to ignite the air-fuel mixture with an electric spark. Technavio’s analysts forecast the global two-wheeler spark plugs market to grow at a CAGR of 6.49% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospects of the global …
- SSE plc：石油・ガスバリューチェーン分析レポート2013SSE plc Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "SSE plc" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “SSE plc”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company’s business structure, …
- 陸地地震装置および取得の世界市場2016-2026The land seismic equipment and acquisition markets are important to follow as spending and trends within these markets indicate future locations for drilling and resource exploitation. The oil price collapse has caused a sharp decline in land seismic acquisition contract awards and CAPEX on equipment. Visiongain expects spending to recover gradually in line with the anticipated oil price recovery, …
- 世界の化学的増進石油回収法（EOR）市場予測：ポリマー、バイオポリマー、界面活性剤、CDG、SP、ASPIncreasing demand for oil is leading to an ever constricting supply-demand balance. As much of the ‘easy oil’ has been produced, operators are increasingly looking to alternative techniques to ensure maximum recovery from their oil reservoirs. This leads to options such as water flooding as well as Enhanced Oil Recovery methods, namely thermal, gas and chemical. Although Chemical EOR is the smalle …
- 世界の海水淡水化市場：多段フラッシュ方式、多重効用法（MED）、逆浸透法、電気透析法About Water Desalination Water desalination refers to the removal of salt and other minerals from saline water. It is used to address fresh water supplies amidst increasing population, industrialization, and pollution. Desalinated water can be used in water drought-hit areas as alternative water source to increase water production yield. Water scarcity in various parts of the globe has become one …
- 世界の携帯用酸素濃縮器市場2015The Global Portable Oxygen Concentrators Industry Report 2015 is a professional and in-depth study on the current state of the Portable Oxygen Concentrators industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Portable Oxygen Concentrators market analysis is provided for the international markets inclu …
- 世界のペプチド治療市場及びパイプラインインサイトWith a very significant role in modulating cell functions, peptides are used in many physiological and pathological processes. The peptide drugs are of late being increasingly used in treatment of certain specific human diseases, which has increased the demand in this market. Previously peptide drugs were not very popular. However, in recent years, as the total number of small molecule-based drugs …
